Patents Assigned to Bayer
  • Process for preparing dihydroisoxazole derivatives
    Patent number: 9796690
    Abstract: The present invention relates to a novel process for preparing dihydroisoxazole derivatives.
    Type: Grant
    Filed: May 27, 2015
    Date of Patent: October 24, 2017
    Assignee: Bayer CropScience Aktiengesellschaft
    Inventors: Günter Hömberger, Mark James Ford, Andreas Hügel, Tomoki Tsuchiya
  • Graphical user interface
    Patent number: 9795539
    Abstract: In order to monitor the administration of medicament portions Ta in a reliable and simple manner, the invention provides a display device for a dispenser for medicament portions Ta, it being necessary to administer the medicament portions at regularly recurring reference administration times, and the display device comprising a display 1 and an electronic actuation means for the display, characterized in that the display comprises a first visualization means 30, 40 for displaying a first period of time between a first reference administration time and the current time, and the first reference administration time being distinguished in that the medicament portion has not been taken by the first reference administration time.
    Type: Grant
    Filed: January 8, 2015
    Date of Patent: October 24, 2017
    Assignee: BAYER INTELLECTUAL PROPERTY GMBH
    Inventors: Heike Grützmacher, Mayk Kresse
  • Binary fungicidal composition
    Patent number: 9795135
    Abstract: The present invention relates to novel compositions and/or formulations, to a process for preparing these compositions and/or formulations and to the use thereof as biologically active compositions and biologically active compositions and/or formulations, especially for the control of phytopathogenic fungi in plants, in the protection of materials and as plant growth regulators.
    Type: Grant
    Filed: July 23, 2014
    Date of Patent: October 24, 2017
    Assignee: BAYER CROPSCIENCE AKTIENGESELLSCHAFT
    Inventors: Andreas Goertz, Mazen Es-Sayed
  • Method for producing 1-indanoles and 1-indanamines
    Patent number: 9796737
    Abstract: A description is given of a process for preparing 1-indanols and 1-indanamines by palladium-catalyzed arylation and of the use thereof as intermediates for the synthesis of fine chemicals and of active agrochemical ingredients.
    Type: Grant
    Filed: January 23, 2015
    Date of Patent: October 24, 2017
    Assignee: Bayer CropScience Aktiengesellschaft
    Inventors: Mark James Ford, Jean-Pierre Vors, Olivier Baudoin, Simon Janody
  • Method for increasing the vigor and/or crop yield of agricultural plants under essentially non-existent pathogen pressure
    Patent number: 9795138
    Abstract: The present invention relates to a method for increasing the vigor and/or crop yield of agricultural plants under essentially non-existent pathogen pressure, wherein the plants, the plant propagules, the seed of the plants and/or a locus where the plants are growing or are intended to grow are treated with an effective amount of a composition comprising a Bacillus subtilis strain with NRRL Accession No. B-21661, a mutant of the strain having all the identifying characteristics of the strain, or a cell-free extract thereof; and a compound selected from the group consisting of fosetyl, fosetyl-aluminum, propamocarb, and propamocarb hydrochloride; wherein the vigor and/or crop yield of agricultural plants under essentially non-existent pathogen pressure is increased.
    Type: Grant
    Filed: March 18, 2015
    Date of Patent: October 24, 2017
    Assignee: Bayer CropScience LP
    Inventors: Markus Frank, David Ernest Silva
  • GLA DOMAINS AS TARGETING AGENTS
    Publication number: 20170296624
    Abstract: The disclosure relates to the recombinant Gla domain proteins and their use targeting phosphatidylserine (PtdS) moieties on the surface of cells, particularly those expressing elevated levels of PtdS, such as cells undergoing apoptosis.
    Type: Application
    Filed: June 23, 2017
    Publication date: October 19, 2017
    Applicant: Bayer HealthCare LLC
    Inventors: Maxine BAUZON, Terry HERMISTON
  • Anthranilamide derivatives as pesticides
    Patent number: 9790202
    Abstract: The present invention relates to novel anthranilamide derivatives of the general formula (I) in which R1, R2, R3, R4, R5, R6, A, Q, Y and n are each as defined in the description—, to the use thereof as insecticides and acaricides for control of animal pests, and to several processes for preparation thereof.
    Type: Grant
    Filed: July 8, 2011
    Date of Patent: October 17, 2017
    Assignee: BAYER INTELLECTUAL PROPERTY GMBH
    Inventors: Rüdiger Fischer, Ernst Rudolf Gesing, Christoph Grondal, Markus Heil, Heinz-Juergen Wroblowsky, Arnd Voerste, Ulrich Gorgens
  • Dose estimation service system configured to support multiple computerized medical imaging scan providers
    Patent number: 9792680
    Abstract: Techniques are disclosed for estimating patient radiation exposure during computerized tomography (CT) scans. More specifically, embodiments of the invention provide efficient approaches for generating a suitable patient model used to make such an estimate, to approaches for estimating patient dose by interpolating the results of multiple simulations, and to approaches for a service provider to host a dose estimation service made available to multiple CT scan providers.
    Type: Grant
    Filed: January 19, 2015
    Date of Patent: October 17, 2017
    Assignee: BAYER HEALTHCARE LLC
    Inventors: Gregory Couch, James Couch
  • Liquid preparation for biological plant protection, method for producing it and use thereof
    Patent number: 9788551
    Abstract: The invention relates to a liquid preparation comprising biologically active fungi and/or fungal organs and/or other microorganisms in a suspension, to a method for producing it and to the use thereof for biological protection of plants, for biological plant strengthening, or for biological soil improvement. Polyether-modified trisiloxane is a preferred liquid used. The preparation according to the invention is notable for easily manageable storage at room temperature, trouble-free transport, and simplicity of production and application.
    Type: Grant
    Filed: May 18, 2012
    Date of Patent: October 17, 2017
    Assignee: Bayer CropScience Biologies GmbH
    Inventor: Peter Lüth
  • Use of succinate dehydrogenase inhibitors and/or respiratory chain complex III inhibitors for improving the ratio of harmful to beneficial microorganisms
    Patent number: 9788540
    Abstract: The present invention relates to the use of succinate dehydrogenase inhibitors and/or complex III inhibitors for controlling undesired fungal pathogens and simultaneously improving the ratio of harmful to beneficial microorganisms in crops and to a method for treating crops or parts of crops for controlling undesired fungal pathogens and simultaneously improving the ratio of harmful to beneficial microorganisms by treating the crops or parts of crops with a succinate dehydrogenase inhibitor and/or a complex III inhibitor.
    Type: Grant
    Filed: July 25, 2011
    Date of Patent: October 17, 2017
    Assignee: BAYER INTELLECTUAL PROPERTY GMBH
    Inventors: Lorianne Fought, Herbert Young, George Musson, Gilbert Labourdette, Dominique Steiger, Heiko Rieck
  • Disubstituted 5-fluoro pyrimidine derivatives containing a sulfondiimine group
    Patent number: 9790189
    Abstract: The present invention relates to 5-fluoro pyrimidine derivatives containing a sulfondiimine group of general formula (I) as described and defined herein, and methods for their preparation, their use for the treatment and/or prophylaxis of disorders, in particular of hyper-proliferative disorders and/or virally induced infectious diseases and/or of cardiovascular diseases. The invention further relates to intermediate compounds useful in the preparation of said compounds of general formula (I).
    Type: Grant
    Filed: March 27, 2015
    Date of Patent: October 17, 2017
    Assignee: Bayer Pharma Aktiengesellschaft
    Inventors: Ulrich Lücking, Arne Scholz, Philip Lienau, Gerhard Siemeister, Rolf Bohlmann, Ulf Bömer
  • Preparation of piperidine-4-carbothioamide
    Patent number: 9790182
    Abstract: The present invention describes a novel process for preparing piperidine-4-carbothioamide.
    Type: Grant
    Filed: June 8, 2015
    Date of Patent: October 17, 2017
    Assignee: Bayer CropScience Aktiengesellschaft
    Inventors: Marco Brünjes, Mark James Ford
  • SUBSTITUTED OXOPYRIDINE DERIVATIVES
    Publication number: 20170291892
    Abstract: The invention relates to substituted oxopyridine derivatives and to processes for preparation thereof, and also to the use thereof for production of medicaments for treatment and/or prophylaxis of diseases, especially of cardiovascular disorders, preferably thrombotic or thromboembolic disorders, and oedemas, and also ophthalmic disorders.
    Type: Application
    Filed: September 22, 2015
    Publication date: October 12, 2017
    Applicant: BAYER PHARMA AKTIENGESELLSCHAFT
    Inventors: Susanne RÖHRIG, Eloisa JIMENEZ-NUNEZ, Karl-Heinz SCHLEMMER, Adrian TERSTEEGEN, Henrik TELLER, Alexander HILLISCH, Stefan HEITMEIER, Martina Victoria SCHMIDT, Jens ACKERSTAFF, Jan STAMPFUß
  • Antibodies capable of binding to the coagulation Factor XI and/or its activated form factor Xia and uses thereof
    Patent number: 9783614
    Abstract: The present invention relates to antibodies capable of binding to the coagulation Factor XI and/or its activated form factor XIa and methods of use thereof, particularly methods of use as agents inhibiting platelet aggregation and by this inhibits thrombus formation.
    Type: Grant
    Filed: May 8, 2013
    Date of Patent: October 10, 2017
    Assignee: Bayer Pharma Aktiengesellschaft
    Inventors: Andreas Wilmen, Julia Straβburger, Frank Dittmer, Michael Strerath, Anja Buchmüller, Joanna Grudzinska-Goebel, Ricarda Finnern, Martina Schäfer, Christoph Gerdes, Hannah Jöriβen, Asako Itakura, Philberta Leung, Erik Tucker
  • Crystalline form of 2-{3-[2-(1-{[3,5-bis(difluoromethyl)-1H-pyrazol-1-yl]acetyl}piperidin-4-yl)-1, 3-thiazol-4-yl]-4,5-dihydro-1,2-oxazol-5-yl}-3-chlorophenylmethanesulphonate
    Patent number: 9783534
    Abstract: The present invention relates to a novel crystalline form of 2-{3-[2-(1-{[3,5-bis(difluoromethyl)-1H-pyrazol-1-yl]acetyl}piperidin-4-yl)-1,3-thiazol-4-yl]-4,5-dihydro-1,2-oxazol-5-yl}-3-chlorophenylmethansulphonate, to processes for its preparation and to its use in agrochemical preparations.
    Type: Grant
    Filed: October 13, 2014
    Date of Patent: October 10, 2017
    Assignee: BAYER CROPSCIENCE AKTIENGESELLSCHAFT
    Inventors: Britta Olenik, Stefan Hillebrand, Pierre Wasnaire, Martin Weiss, Ulrike Wachendorff-Neumann
  • Six-membered C-N-linked aryl sulfide derivatives and aryl sulfoxide derivatives as pest conrol agents
    Patent number: 9783509
    Abstract: The present invention relates to novel heterocyclic compounds, to processes for preparation thereof and to the use thereof for controlling animal pests, which include arthropods and especially insects and acarids.
    Type: Grant
    Filed: July 4, 2014
    Date of Patent: October 10, 2017
    Assignee: BAYER CROPSCIENCE AKTIENGESELLSCHAFT
    Inventors: Bernd Alig, Silvia Cerezo-Galvez, Reiner Fischer, Adeline Köhler, Julia Johanna Hahn, Kerstin Ilg, Peter Lösel, Olga Malsam, Daniela Portz
  • Methods and compositions for controlling weed infestation and improving grass quality
    Patent number: 9781934
    Abstract: Methods for controlling unwanted vegetation, such as weeds, to turfgrass by applying an active compound combination including a triazolinone herbicide, for example, sulfonylamino-carbonyl-triazolinone, and at least one sulfonylurea herbicides, to turfgrass is described herein. The disclosure also provides for active compound combinations and methods of improving turfgrass quality.
    Type: Grant
    Filed: May 24, 2013
    Date of Patent: October 10, 2017
    Assignee: BAYER CROPSCIENCE LP
    Inventors: Bruce Spesard, Don Myers, Laurence Mudge, Matt Bradley
  • Aminoimidazopyridazines
    Patent number: 9783543
    Abstract: The present invention relates to amino-substituted imidazopyridazine compounds of general formula (I), in which A, R1, R2, R3, R4 and n are as defined in the claims, to methods of preparing said compounds, to intermediate compounds useful for preparing said compounds, to pharmaceutical compositions and combinations comprising said compounds and to the use of said compounds for manufacturing a pharmaceutical composition for the treatment or prophylaxis of a disease, in particular of a hyper-proliferative and/or angiogenesis disorder, as a sole agent or in combination with other active ingredients.
    Type: Grant
    Filed: November 14, 2013
    Date of Patent: October 10, 2017
    Assignee: BAYER PHARMA AKTIENGESELLSCHAFT
    Inventors: Ludwig Zorn, Knut Eis, Volker Schulze, Detlev Sülzle, Florian Puehler, Philip Lienau, Ulf Bömer, Kirstin Petersen, Andrea Hägebarth
  • DIAMINOHETEROARYL SUBSTITUTED INDAZOLES
    Publication number: 20170283396
    Abstract: Compounds of formula (I) which are inhibitors of Bub 1 kinase, processes for their production and their use as pharmaceuticals.
    Type: Application
    Filed: March 28, 2017
    Publication date: October 5, 2017
    Applicant: Bayer Pharma Aktiengesellschaft
    Inventors: Christoph-Stephan HILGER, Marion HITCHCOCK, Hans BRIEM, Gerhard SIEMEISTER, Amaury Ernesto FERNANDEZ-MONTALVAN, Jens SCHRÖDER, Simon HOLTON, Cornelia PREUßE, Karsten DENNER
  • 3-aryl-substituted imidazo[1,2-A]pyridines and their use
    Patent number: 9776997
    Abstract: The present application relates to novel 3-aryl-substituted imidazo[1,2-a]pyridines, to processes for preparation thereof, to the use thereof, alone or in combinations, for treatment and/or prophylaxis of diseases, and to the use thereof for production of medicaments for treatment and/or prophylaxis of diseases, especially for treatment and/or prophylaxis of cardiovascular disorders.
    Type: Grant
    Filed: June 4, 2014
    Date of Patent: October 3, 2017
    Assignee: BAYER PHARMA AKTIENGESELLSCHAFT
    Inventors: Alexandros Vakalopoulos, Markus Follmann, Ingo Hartung, Philipp Buchgraber, Alexey Gromov, Niels Lindner, Frank Wunder, Johannes-Peter Stasch, Gorden Redlich, Volkhart Min-Jian Li